A Study of Freeze-Dried Miracle Fruit (MiraBurst) on Participants Receiving Cancer Treatment
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorCase Comprehensive Cancer Center
About this trial
This study is for people with a diagnosis of solid tumor cancer who are experiencing changes in taste perception due to cancer treatment. Changes in taste perception, also known as dysgeusia, is a frequent side effect of cancer treatment and can significantly impacts quality of life. These alterations may be temporary or, in some cases, permanent.
The purpose of this study is determine whether freeze dried miracle fruit, marketed as MiraBurst can improve taste perception in this group of people. Participants involved in this study will be asked to take one MiraBurst mini-square upto four times a day, prior to eating, for 90 days.
Eligibility criteria
Qualifiers
Age 18 years and above
Solid tumor cancer diagnosis
Participants on active cancer treatment
Eastern Cooperative Oncology Group (ECOG) score of 0 to 2
Disqualifiers
Grade 2 dysgeusia prior to starting cancer treatment
Participants with severe dementia, severe neurological illness who are unable to understand the study or provide informed consent
Participants on enteral and parenteral nutrition
Participants with eating disorders
Trial design
Treatments tested in this trial
- MiraBurst
Treatment groups
45 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov